B. Riley Securities Initiates Coverage On Orchestra BioMed Hldgs with Buy Rating, Announces Price Target of $15
Portfolio Pulse from Benzinga Newsdesk
B. Riley Securities has initiated coverage on Orchestra BioMed Holdings (NASDAQ:OBIO) with a Buy rating and a price target of $15.
July 25, 2024 | 5:29 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
B. Riley Securities has initiated coverage on Orchestra BioMed Holdings with a Buy rating and a price target of $15.
The initiation of coverage with a Buy rating and a price target of $15 by B. Riley Securities is likely to positively impact the stock price of Orchestra BioMed Holdings in the short term. Analyst ratings and price targets are significant indicators for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100